For many people, losing weight is not just about appearance. It can affect energy levels, confidence, mobility and long-term health. Yet despite countless diets and fitness trends, maintaining significant weight loss has remained a challenge for millions.
Now, experts writing in the American Gastroenterological Association's journal Gastroenterology believe the recent success of drugs such as Ozempic, Wegovy and Zepbound may be only the first step in a much larger transformation of obesity care, reports Science Daily.
A new era
The arrival of GLP-1 medications has changed the treatment landscape dramatically. These drugs have helped many patients achieve levels of weight loss that were previously difficult without surgery.
But researchers argue that obesity treatment is evolving beyond medication alone. Increasingly, specialists are viewing obesity as a complex chronic disease that requires a broader and more individualized approach.
Also read: Resistance training can reduce the risk of heart attacks by 44 percent
As a result, doctors are beginning to combine different treatment options rather than relying on a single solution.
More than medication
One area attracting growing interest is the use of minimally invasive endoscopic procedures. These treatments can help patients lose weight without traditional surgery and may offer another option for people seeking long-term results.
Bariatric surgery also remains an important tool, particularly for patients with severe obesity or obesity-related health conditions.
Experts believe future treatment strategies could combine:
Also read: This is what happens to your body when you eat garlic every day
- Weight-loss medications
- Endoscopic procedures
- Bariatric surgery
- Genetic insights
- Personalized treatment plans
Looking ahead
Researchers also point to advances in precision medicine as a potential game changer. As scientists learn more about the biological and genetic factors linked to obesity, doctors may eventually be able to predict which treatments are most likely to work for individual patients.
According to the authors, the goal is shifting from simply reducing body weight to managing obesity as a long-term disease and improving overall health outcomes.
While medications such as Ozempic have captured public attention, experts say the future of obesity treatment will likely involve a combination of therapies tailored to each patient rather than a one-size-fits-all solution.
Also read: Birth control pills may affect your appetite, new study suggests
Also read: Tired people face higher risk of high blood pressure